Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease

Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease

Introduction: Randomized clinical trials should be complemented with data from real-world studies. We report our long-term experience with safinamide in a movement disorders unit. Methods: This retrospective study included patients with Parkinson’s disease (PD) treated with safinamide in our unit fr...

Full description

Bibliographic Details
Main Authors: Anna Planas-Ballvé, Núria Caballol Pons, Alejandro Peral Quirós, Isabel Gómez Ruiz, Marta Balagué Marmaña, Alexander J. Velázquez Ballester, Dolors Lozano Moreno, Asunción Ávila Rivera
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Brain Sciences
Subjects:
Parkinson’s disease
safinamide
MAO-B inhibitor
real-world evidence
discontinuation rate
motor symptoms
Online Access:https://www.mdpi.com/2076-3425/14/12/1238

Internet

https://www.mdpi.com/2076-3425/14/12/1238

Similar Items